➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts

Last Updated: September 20, 2020

DrugPatentWatch Database Preview

Patent: 9,605,070

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,605,070
Title:Antibody molecules to TIM-3 and uses thereof
Abstract: Antibody molecules that specifically bind to TIM-3 are disclosed. The anti-TIM-3 antibody molecules can be used to treat, prevent and/or diagnose immune, cancerous, or infectious conditions and/or disorders.
Inventor(s): Sabatos-Peyton; Catherine Anne (Cambridge, MA), Brannetti; Barbara (Basel, CH), Harris; Alan S. (Cambridge, MA), Huber; Thomas (Basel, CH), Pietzonka; Thomas (Basel, CH), Mataraza; Jennifer Marie (Cambridge, MA), Blattler; Walter A. (Brookline, MA), Hicklin; Daniel J. (Montclair, NJ), Vasquez; Maximiliano (Palo Alto, CA), DeKruyff; Rosemarie H. (Portola Valley, CA), Umetsu; Dale T. (Portola Valley, CA), Freeman; Gordon James (Brookline, MA), Hu; Tiancen (Cambridge, MA), Taraszka; John A. (Cambridge, MA), Xu; Fangmin (Cambridge, MA)
Assignee: Novartis AG (Basel, CH) DANA-FARBER CANCER INSTITUTE, INC. (Boston, MA) Children\'s Medical Center Corporation (Boston, MA)
Application Number:14/610,837
Patent Claims:see list of patent claims

Details for Patent 9,605,070

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Bristol Myers Squibb YERVOY ipilimumab INJECTABLE; INJECTION 125377 001 2011-03-25   Start Trial Novartis AG (Basel, CH) DANA-FARBER CANCER INSTITUTE, INC. (Boston, MA) Children\'s Medical Center Corporation (Boston, MA) 2034-01-31 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.